Trademark: 90327967
Status Date
Monday, August 28, 2023
Filing Date
Wednesday, November 18, 2020
Published for Opposition
Tuesday, June 1, 2021
Abandoned Date
Monday, August 28, 2023
5 Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
Aug 28, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Aug 28, 2023
Abandonment - No Use Statement Filed
Dec 21, 2022
Notice Of Approval Of Extension Request E-Mailed
Dec 19, 2022
Sou Extension 3 Granted
Dec 19, 2022
Sou Extension 3 Filed
Dec 19, 2022
Sou Teas Extension Received
Jun 29, 2022
Notice Of Approval Of Extension Request E-Mailed
Jun 27, 2022
Sou Extension 2 Granted
Jun 27, 2022
Sou Extension 2 Filed
Jun 27, 2022
Sou Teas Extension Received
Jan 7, 2022
Notice Of Approval Of Extension Request E-Mailed
Jan 5, 2022
Sou Extension 1 Granted
Jan 5, 2022
Sou Extension 1 Filed
Jan 5, 2022
Sou Teas Extension Received
Nov 24, 2021
Teas Change Of Correspondence Received
Nov 24, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 24, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 27, 2021
Noa E-Mailed - Sou Required From Applicant
Jun 1, 2021
Official Gazette Publication Confirmation E-Mailed
Jun 1, 2021
Published For Opposition
May 12, 2021
Notification Of Notice Of Publication E-Mailed
Apr 27, 2021
Approved For Pub - Principal Register
Apr 21, 2021
Assigned To Examiner
Jan 25, 2021
New Application Office Supplied Data Entered
Nov 21, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
